Medicare Enrolled

Dr. Andrea Edwards, MD

Medical Oncology · Santa Cruz, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1663 DOMINICAN WAY STE 210, Santa Cruz, CA 95065
8314758002
In practice since 2006 (19 years)
NPI: 1255341962 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Edwards from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Edwards? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Edwards

Dr. Andrea Edwards is a medical oncology specialist in Santa Cruz, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Edwards performed 484 Medicare services across 160 unique beneficiaries.

Between the years covered by Open Payments, Dr. Edwards received a total of $31,883 from 69 pharmaceutical and/or device companies across 736 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Edwards is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 484 Medicare services $31,883 industry payments

Medicare Practice Summary

Medicare Utilization ↗
484
Medicare services
Bottom 44% in CA for medical oncology
160
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~25 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
252 $103 $235
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
140 $151 $325
Prolonged inpatient or observation care, each additional 15 minutes
This code is used for prolonged hospital inpatient or observation care services that extend beyond the total time required for the primary evaluation and management service. It covers each additional 15-minute increment of time spent by the provider.
49 $25 $58
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
43 $99 $325
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$31,883
Total received (2018-2024)
Avg $4,555/year across 7 years
Top 24% in CA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
736
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,113 (50.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,351 (41.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,439 (4.5%)
Other
Charitable contributions, space rental, and other categories
$980 (3.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,832
2023
$2,968
2022
$4,294
2021
$3,140
2020
$3,357
2019
$13,145
2018
$3,147

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$618
Janssen Biotech, Inc.
$322
Aveo Pharmaceuticals, Inc.
$182
Lilly USA, LLC
$99
Eisai Inc.
$80
Celgene Corporation
$70
Genmab U.S., Inc.
$57
PFIZER INC.
$45
ARRAY BIOPHARMA INC
$33
Merck Sharp & Dohme LLC
$32
ABBVIE INC.
$31
Gilead Sciences, Inc.
$31
Genentech USA, Inc.
$30
Coherus Biosciences Inc.
$25
SERVIER PHARMACEUTICALS LLC
$24
Mirati Therapeutics, Inc.
$24
GlaxoSmithKline, LLC.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$23
Ipsen Biopharmaceuticals, Inc
$22
Astellas Pharma US Inc
$22
Incyte Corporation
$21
Rigel Pharmaceuticals, Inc.
$15
Top 3 companies account for 61.3% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$9,164
AstraZeneca Pharmaceuticals LP
$4,434
Novartis Pharmaceuticals Corporation
$3,271
E.R. Squibb & Sons, L.L.C.
$1,866
Celgene Corporation
$1,652
Seagen Inc.
$955
Lilly USA, LLC
$908
PFIZER INC.
$703
Takeda Pharmaceuticals U.S.A., Inc.
$658
Amgen Inc.
$566
NOVARTIS PHARMACEUTICALS CORPORATION
$522
Incyte Corporation
$471
Bayer HealthCare Pharmaceuticals Inc.
$389
GlaxoSmithKline, LLC.
$378
Rigel Pharmaceuticals, Inc.
$348
GENZYME CORPORATION
$321
Genentech USA, Inc.
$298
AbbVie Inc.
$279
Eisai Inc.
$274
Gilead Sciences, Inc.
$249
Foundation Medicine, Inc.
$235
Octapharma USA, Inc.
$232
Daiichi Sankyo Inc.
$208
AbbVie, Inc.
$187
Aveo Pharmaceuticals, Inc.
$182
Seattle Genetics, Inc.
$163
Merck Sharp & Dohme Corporation
$151
AVEO Pharmaceuticals, Inc.
$148
TESARO, Inc.
$134
Kite Pharma, Inc.
$134
Myriad Genetic Laboratories, Inc.
$128
TerSera Therapeutics LLC
$127
Mirati Therapeutics, Inc.
$126
Epizyme, Inc.,
$124
Dova Pharmaceuticals
$119
MEDIVATION FIELD SOLUTIONS LLC
$114
Sirtex Medical Inc
$113
Regeneron Healthcare Solutions, Inc.
$108
SANOFI-AVENTIS U.S. LLC
$100
ABBVIE INC.
$94
Alexion Pharmaceuticals, Inc.
$88
Acrotech Biopharma LLC
$77
EISAI INC.
$69
Clovis Oncology, Inc.
$68
Puma Biotechnology, Inc.
$61
ARRAY BIOPHARMA INC
$59
Karyopharm Therapeutics Inc.
$59
Teva Pharmaceuticals USA, Inc.
$57
Genmab U.S., Inc.
$57
Stemline Therapeutics Inc.
$54
Merck Sharp & Dohme LLC
$50
SERVIER PHARMACEUTICALS LLC
$48
Coherus Biosciences Inc.
$45
Agios Pharmaceuticals, Inc.
$43
Ipsen Biopharmaceuticals, Inc
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
Adaptive Biotechnologies Corporation
$39
Apellis Pharmaceuticals, Inc.
$35
Heron Therapeutics, Inc.
$34
SOBI, INC
$26
Shire North American Group Inc
$25
Exelixis Inc.
$24
TAIHO ONCOLOGY, INC.
$24
Astellas Pharma US Inc
$22
Siemens Medical Solutions USA, Inc.
$22
Fortovia Therapeutics, Inc.
$21
Otsuka America Pharmaceutical, Inc.
$21
Advanced Accelerator Applications
$20
Secura Bio, Inc.
$18
Top 3 companies account for 52.9% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKEEGA · ALUNBRIG · ARIA Radiation Therapy Management Software · AUGTYRO · Abraxane · Alecensa · Aliqopa · BALVERSA · BAVENCIO · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · Balversa · CALQUENCE · CINVANTI · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELITEK · ELREXFIO · ENHERTU · ERBITUX · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · FARYDAK · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE LIQUID · GILOTRIF · HEMADY · Herceptin · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MYLOTARG · MYRISK · NINLARO · NUWIQ · Nerlynx · Nexavar · Nplate · Nubeqa · OCTAPLAS · OJJAARA · ONCASPAR · OPDIVO · Onivyde · Orserdu · PADCEV · PIQRAY · PROMACTA · Padcev · Perjeta · Pomalyst · PreciseTumor · REBLOZYL · RETEVMO · RYDAPT · Revlimid · Rezlidhia · Rubraca · SCEMBLIX · SIMPONI ARIA · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trodelvy · Udenyca · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XPOVIO · XTANDI · Xofigo · ZEJULA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (50%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a medical oncology specialist in Santa Cruz?
Compare medical oncologists in the Santa Cruz area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
10
Per 100K population
3.8
County median income
$109,266
Nearest hospital
DOMINICAN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Edwards is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Edwards experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Edwards performed 252 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Edwards receive payments from pharmaceutical companies?
Yes. Dr. Edwards received a total of $31,883 from 69 companies across 736 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Edwards's costs compare to other medical oncologists in Santa Cruz?
Dr. Edwards's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Edwards) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →